Provenge is horribly expensive vaccine. So far the vaccine has the advantage that it is alone on the market. DNDN must dramatically reduce costs. For example, manufacturing value NeuVax (company"GALE" - in SPA phase III fast track) is just under $ 1000
many drugs get to phase 3 and most fail. Provenge is FDA approved and is a one time 3 infusion protocol at 93K. When you compare and factor in the cost of other meds and chemo with their side effects and extended hospital stays, compare apples to apples, Provenge imo is more cost effective. A friend was treated for breast cancer, her cost based on insurance records is over $900K. In the long run, I predict that immune therapy will be more cost effective.